$2.85
0.145.17%
At close: -
$2.80
-0.05-1.75%
After Hours: Dec 20, 6:39 PM EDT
Comments
Loading...
AbCellera Biologics (NASDAQ:ABCL) Stock, Earnings Estimates, EPS, And Revenue
AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 18
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$7.6M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$33M
Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.
Data brought to you by Benzinga APIs
AbCellera Biologics (ABCL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-04 | $-0.17 | $-0.15 | -13.3 % |
| Jun 2024 | 2024-08-06 | $-0.13 | $-0.14 | 7.14 % |
| Mar 2024 | 2024-05-07 | $-0.14 | $-0.17 | 17.6 % |
| Dec 2023 | 2024-02-20 | $-0.16 | $-0.13 | -23.1 % |
AbCellera Biologics (ABCL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-04 | $6.51M | $7.95M | -18.1 % |
| Jun 2024 | 2024-08-06 | $7.32M | $10.15M | -27.9 % |
| Mar 2024 | 2024-05-07 | $9.95M | $10.84M | -8.17 % |
| Dec 2023 | 2024-02-20 | $9.18M | $8.88M | 3.37 % |
FAQ
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics (ABCL) is scheduled to report earnings on February 18, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?
The Actual EPS was $-0.17, which missed the estimate of $-0.15.
What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?
The Actual Revenue was $6.5M, which missed the estimate of $8M.
Browse earnings estimates, EPS, and revenue on all stocks.